Clinical utility of implantable neurostimulation devices in the treatment of chronic migraine

John A Freeman, Terrance L Trentman Department of Anesthesiology, Division of Pain Medicine, Mayo Clinic Arizona, Phoenix, AZ, USA Abstract: Chronic migraine is a disabling disorder that is costly to individuals and society. Occipital nerve stimulation has been used to treat refractory cases of prim...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Freeman JA, Trentman TL
Formato:	article
Lenguaje:	EN
Publicado:	Dove Medical Press 2013
Materias:	Medical technology R855-855.5
Acceso en línea:	https://doaj.org/article/6bd46b8679004de39f4c5918d61acc51
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

id	oai:doaj.org-article:6bd46b8679004de39f4c5918d61acc51
record_format	dspace
spelling	oai:doaj.org-article:6bd46b8679004de39f4c5918d61acc512021-12-02T03:44:20ZClinical utility of implantable neurostimulation devices in the treatment of chronic migraine1179-1470https://doaj.org/article/6bd46b8679004de39f4c5918d61acc512013-11-01T00:00:00Zhttp://www.dovepress.com/clinical-utility-of-implantable-neurostimulation-devices-in-the-treatm-a15031https://doaj.org/toc/1179-1470John A Freeman, Terrance L Trentman Department of Anesthesiology, Division of Pain Medicine, Mayo Clinic Arizona, Phoenix, AZ, USA Abstract: Chronic migraine is a disabling disorder that is costly to individuals and society. Occipital nerve stimulation has been used to treat refractory cases of primary headache disorders including drug-resistant chronic cluster headaches and chronic migraine. The Food and Drug Administration (FDA) off-labeled application of equipment used for peripheral nerve (occipital) stimulation is borrowed from FDA-labeled spinal cord stimulation. Manufacturer-sponsored randomized trials include a feasibility study (ONSTIM-Medtronic) and a safety and efficacy study (St Jude). A non-industry sponsored prospective, randomized crossover study by Serra and Marchiotretto suggests improved quality of life and a significant reduction in medication use. Though preliminary studies suggest occipital nerve stimulation is safe and efficacious in treating chronic migraine headache, complication rates, including lead migration, lead fracture, and surgical site infections remain high. Further studies are needed to demonstrate long-term outcomes, while improved surgical techniques and site-specific equipment are needed to minimize complications. Keywords: headache, occipital nerve stimulation, peripheral nerve stimulation, neuromodulation, electrical stimulation therapyFreeman JATrentman TLDove Medical PressarticleMedical technologyR855-855.5ENMedical Devices: Evidence and Research, Vol 2013, Iss default, Pp 195-201 (2013)
institution	DOAJ
collection	DOAJ
language	EN
topic	Medical technology R855-855.5
spellingShingle	Medical technology R855-855.5 Freeman JA Trentman TL Clinical utility of implantable neurostimulation devices in the treatment of chronic migraine
description	John A Freeman, Terrance L Trentman Department of Anesthesiology, Division of Pain Medicine, Mayo Clinic Arizona, Phoenix, AZ, USA Abstract: Chronic migraine is a disabling disorder that is costly to individuals and society. Occipital nerve stimulation has been used to treat refractory cases of primary headache disorders including drug-resistant chronic cluster headaches and chronic migraine. The Food and Drug Administration (FDA) off-labeled application of equipment used for peripheral nerve (occipital) stimulation is borrowed from FDA-labeled spinal cord stimulation. Manufacturer-sponsored randomized trials include a feasibility study (ONSTIM-Medtronic) and a safety and efficacy study (St Jude). A non-industry sponsored prospective, randomized crossover study by Serra and Marchiotretto suggests improved quality of life and a significant reduction in medication use. Though preliminary studies suggest occipital nerve stimulation is safe and efficacious in treating chronic migraine headache, complication rates, including lead migration, lead fracture, and surgical site infections remain high. Further studies are needed to demonstrate long-term outcomes, while improved surgical techniques and site-specific equipment are needed to minimize complications. Keywords: headache, occipital nerve stimulation, peripheral nerve stimulation, neuromodulation, electrical stimulation therapy
format	article
author	Freeman JA Trentman TL
author_facet	Freeman JA Trentman TL
author_sort	Freeman JA
title	Clinical utility of implantable neurostimulation devices in the treatment of chronic migraine
title_short	Clinical utility of implantable neurostimulation devices in the treatment of chronic migraine
title_full	Clinical utility of implantable neurostimulation devices in the treatment of chronic migraine
title_fullStr	Clinical utility of implantable neurostimulation devices in the treatment of chronic migraine
title_full_unstemmed	Clinical utility of implantable neurostimulation devices in the treatment of chronic migraine
title_sort	clinical utility of implantable neurostimulation devices in the treatment of chronic migraine
publisher	Dove Medical Press
publishDate	2013
url	https://doaj.org/article/6bd46b8679004de39f4c5918d61acc51
work_keys_str_mv	AT freemanja clinicalutilityofimplantableneurostimulationdevicesinthetreatmentofchronicmigraine AT trentmantl clinicalutilityofimplantableneurostimulationdevicesinthetreatmentofchronicmigraine
_version_	1718401632820002816

Clinical utility of implantable neurostimulation devices in the treatment of chronic migraine

Ejemplares similares